Imperial College Reports Dual-Target CAR-iNKT Platform for Multiple Myeloma
Imperial College London investigators reported a peer-reviewed preclinical strategy that combines engineered invariant natural killer T (iNKT) cells with an iNKT-selective bispecific engager in multiple myeloma. Across five CAR endodomain configurations, BCMA-directed CD28z CAR-iNKT…
